MSGERC Grand Rounds Webinar Series
Grand Rounds Webinar Series, Episode 2: Cryptococcosis – Updated Management Strategies (Archived Version)
Check out the archive of the second MSGERC Grand Rounds Webinar. In this episode, Drs John Baddley and Jeremey Walker, with guest Dr David Boulware, discuss updated management strategies in cryptococcosis, with a particular focus on the new data from the AMBITION trial as well as the putative COVID-19 and cryptococcosis connection. Using a case-based approach, they explore topics such as risk factor assessment and optimal therapeutics. The webinar also features commentary from John Perfect, MD.
Cryptococcosis: Updated Management Strategies
Recorded May 27, 2022.
Speakers
John W. Baddley, MD, MSPH
Professor of Medicine
Institute of Human Virology
University of Maryland Stewart and Marlene Greenebaum Cancer Center
Baltimore, Maryland
Jeremey Walker, MD, is Assistant Professor of Medicine and Infectious Diseases in the department of Medicine at the University of Alabama Medical Center. Dr Walker specializes in treatment and prevention of infection in Immune-compromised hosts including solid organ transplant and malignancy. This includes working as an associate healthcare epidemiologist with focus on areas serving this population. Dr Walker earned his Doctor of Medicine, Internship, Residency, and Fellowship at University of Alabama School of Medicine. Dr Walker has published on a range of infectious diseases topics, including the role of fecal microbiota in management of C difficile infection as well as COVID-19 prevention. Most recently, Dr Walker has led an effort to characterize the connection between COVID-19 and cryptococcal infection, particularly in solid organ transplant patients.
This educational initiative was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (CDC-RFA-CK20-2003) to the University of Alabama at Birmingham. The University of Alabama at Birmingham is collaborating with the Mycoses Study Group Education & Research Consortium and Terranova Medica, LLC, on this initiative. The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.
Jeremey Walker, MD
Associate Scientist
Center for Clinical and Translational Science
General Clinical Research Center
Assistant Professor, Medicine
Infectious Diseases, Department of Medicine
University of Alabama Medical Center
Birmingham, Alabama
Jeremey Walker, MD, is Assistant Professor of Medicine and Infectious Diseases in the department of Medicine at the University of Alabama Medical Center. Dr Walker is also an Associate Scientist at the Center for Clinical and Translational Science, as well as the General Clinical Research Center. Dr Walker earned his Doctor of Medicine, Internship, Residency, and Fellowship at University of Alabama School of Medicine. Dr Walker has published on a range of infectious diseases topics, including the role of fecal microbiota in management of C difficile infection as well as COVID-19 prevention. Most recently, Dr Walker has led an effort to characterize the connection between COVID-19 and cryptococcal infection, particularly in solid organ transplant patients.
This educational initiative was funded in part by a cooperative agreement with the Centers for Disease Control and Prevention (CDC-RFA-CK20-2003) to the University of Alabama at Birmingham. The University of Alabama at Birmingham is collaborating with the Mycoses Study Group Education & Research Consortium and Terranova Medica, LLC, on this initiative. The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this resource center do not necessarily represent the policy of CDC or HHS and should not be considered an endorsement by the Federal Government.